These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7455319)

  • 21. [Cellular and humoral immunity in chronic liver diseases].
    Loginov AS; Tsaregorodtseva TM; Zotina MM; Ponomarenko AM; Shmeleva TK
    Vestn Akad Med Nauk SSSR; 1980; (11):47-50. PubMed ID: 6971024
    [No Abstract]   [Full Text] [Related]  

  • 22. [Essential mixed cryoglobulinemia. A prospective study of 21 cases].
    García-Bragado F; Villar M; Vilardell M; Lima J; Monteagudo M; Vallés M; Fort J
    Med Clin (Barc); 1988 Feb; 90(5):190-4. PubMed ID: 3352361
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cellular immunity in patients with chronic liver diseases].
    Makolkin VI; Zozulia TV; Zolotnitskaia RP; Tananaeva IK
    Ter Arkh; 1981; 53(12):100-3. PubMed ID: 6977883
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunological problems of chronic hepatitis.
    Schumacher K
    Quad Sclavo Diagn; 1971 Dec; 7(4):769-87. PubMed ID: 4949875
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical evaluation of various indices of T and B immunity systems in patients with chronic hepatitis and liver cirrhosis].
    Epishina NA; Sytnik IA; Epishin AV
    Vrach Delo; 1983 Aug; (8):94-8. PubMed ID: 6605624
    [No Abstract]   [Full Text] [Related]  

  • 26. Lung involvement in essential mixed cryoglobulinemia.
    Bombardieri S; Paoletti P; Ferri C; Di Munno O; Fornal E; Giuntini C
    Am J Med; 1979 May; 66(5):748-56. PubMed ID: 443251
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypergammaglobulinemia in cirrhosis. Pathogenetic aspects].
    Prytz H
    Med Chir Dig; 1979; 8(1):67-72. PubMed ID: 381798
    [No Abstract]   [Full Text] [Related]  

  • 28. [Spontaneous rosette formation in patients with chronic liver diseases].
    Shmeleva TK
    Lab Delo; 1982; (10):40-1. PubMed ID: 6183498
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cryoglobulinemia and hepatic lesion].
    Pedreira JD; Esteban R
    Med Clin (Barc); 1979 Jan; 72(2):74-5. PubMed ID: 431167
    [No Abstract]   [Full Text] [Related]  

  • 30. Danshao huaxian capsule in treatment of decompensated cirrhosis resulting from chronic hepatitis B.
    Cheng ML; Lu T; Yao YM; Geng XX
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):48-51. PubMed ID: 16481282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of the behavior of serum immunoglobulins in chronic liver diseases].
    De la Revilla L; García Torres JA; Martinez Checa J; Martin-Vivaldi R; Ventín JL; Alemán P; Oliver S
    Rev Esp Enferm Apar Dig; 1973 Nov; 41(5):573-82. PubMed ID: 4770555
    [No Abstract]   [Full Text] [Related]  

  • 32. [Functional and metabolic activity of lymphocytes in chronic hepatitis, liver cirrhosis and chronic cholecystitis].
    Nikolaev AI; Mamutov ZhI; Fazylov AV
    Ter Arkh; 1989; 61(9):109-12. PubMed ID: 2595568
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatic lesions in drug addiction].
    Dal Monte PR; D'Imperio N; Formica G; Giuliani-Piccari G; Marzot G; Milandri G; Piemontese A; Ruggieri M; Sarti F; Spongano P
    G Clin Med; 1981 Feb; 62(2):83-92. PubMed ID: 7239058
    [No Abstract]   [Full Text] [Related]  

  • 34. [Relations between chronic hepatitis and immunoglobulins].
    Incze A; Cândea V; Ilieş A; Dediu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(2):125-30. PubMed ID: 37579
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunoglobulins and Australia antigen in various forms of hepatitis and liver cirrhosis].
    Reis HE; Bertrams J; Selmair H; Wiese W; Kuwert E; Hirche H
    Med Welt; 1974 Aug; 25(31):1277-9. PubMed ID: 4846027
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis B surface antigen in cirrhosis of liver.
    Sharma VK; Prasad FC
    J Indian Med Assoc; 1985 Sep; 83(9):305-7. PubMed ID: 4086851
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
    J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
    Sponseller CA; Bacon BR; Di Bisceglie AM
    Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum antibodies against some viruses in chronic hepatitis and hepatic cirrhosis (author's transl)].
    Petera V; Bruj J
    Cas Lek Cesk; 1974 Jan; 113(2):55-7. PubMed ID: 4434407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.